Alys Pharmaceuticals Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $100M

  • Investors
  • 1

Alys Pharmaceuticals General Information

Description

Developer of an immuno-dermatology platform designed to revolutionize treatment paradigms across various dermatological indications. The company offers an R&D-centric multi-platform pipeline, incorporating asset-centric operational structures and focusing on each asset class within the dermatology vertical for optimized leverage and impact, enabling the healthcare industry to gain access to transformative systems for a spectrum of dermatological conditions.

Contact Information

Website
www.alyspharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 Northern Avenue
  • Boston, MA 02210
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • 100 Northern Avenue
  • Boston, MA 02210
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alys Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 12-Feb-2024 $100M Completed Startup
To view Alys Pharmaceuticals’s complete valuation and funding history, request access »

Alys Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Alys Pharmaceuticals’s complete cap table history, request access »

Alys Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an immuno-dermatology platform designed to revolutionize treatment paradigms across various dermatological
Biotechnology
Boston, MA

Cambridge, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alys Pharmaceuticals Competitors (32)

One of Alys Pharmaceuticals’s 32 competitors is Mersana Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mersana Therapeutics Formerly VC-backed Cambridge, MA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Cytovance Biologics Formerly PE-Backed Oklahoma City, OK
Cerecin Venture Capital-Backed Denver, CO
Aquapharm (Scotland ) Formerly VC-backed Oban, United Kingdom
You’re viewing 5 of 32 competitors. Get the full list »

Alys Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medicxi Venture Capital Minority
To view Alys Pharmaceuticals’s complete investors history, request access »

Alys Pharmaceuticals Acquisitions (3)

Alys Pharmaceuticals’s most recent deal was a Merger/Acquisition with Granular Therapeutics. The deal was made on 12-Feb-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Granular Therapeutics 12-Feb-2024 Merger/Acquisition Drug Discovery
Aldena Therpeutics Merger/Acquisition Drug Discovery
Graegis Pharmaceuticals Merger/Acquisition Drug Delivery
To view Alys Pharmaceuticals’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Alys Pharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Aldena Therpeutics Boston, MA 2021

Alys Pharmaceuticals FAQs

  • When was Alys Pharmaceuticals founded?

    Alys Pharmaceuticals was founded in 2024.

  • Where is Alys Pharmaceuticals headquartered?

    Alys Pharmaceuticals is headquartered in Boston, MA.

  • What industry is Alys Pharmaceuticals in?

    Alys Pharmaceuticals’s primary industry is Biotechnology.

  • Is Alys Pharmaceuticals a private or public company?

    Alys Pharmaceuticals is a Private company.

  • What is the current valuation of Alys Pharmaceuticals?

    The current valuation of Alys Pharmaceuticals is .

  • What is Alys Pharmaceuticals’s current revenue?

    The current revenue for Alys Pharmaceuticals is .

  • How much funding has Alys Pharmaceuticals raised over time?

    Alys Pharmaceuticals has raised $100M.

  • Who are Alys Pharmaceuticals’s investors?

    Medicxi has invested in Alys Pharmaceuticals.

  • Who are Alys Pharmaceuticals’s competitors?

    Mersana Therapeutics, CytomX Therapeutics, Cytovance Biologics, Cerecin, and Aquapharm (Scotland ) are some of the 32 competitors of Alys Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »